Introduction
Stromal interaction molecule 1 (STIM1) is expressed in virtually all eukaryotic cells and it is an essential component of the store-operated Ca 2þ channel (SOCC) function. 1 Primarily identified as an endoplasmic reticulum (ER)-located transmembrane protein, the STIM1 N-terminus faces the ER luminal side and features an EF-hand calcium-binding motif essential for the Ca 2þ sensor function. The cytosolic C-terminus of STIM1 is characterized by the presence of a putative coiled-coil domain. Upon intraluminal Ca 2þ discharge from the ER, STIM1 oligomerizes and translocates toward the junction that connects the ER to the plasma membrane to trigger intracellular Ca 2þ influx through the activation of Orai channels. 2, 3 This cascade of precise cellular events is also known as store-operated Ca 2þ entry (SOCE). [4] [5] [6] In vascular smooth muscle cells (VSMCs), STIM1 and SOCE are crucial elements in the regulation of several cellular functions. SOCE mediated by STIM1 and Orai1 is required for the activation of the nuclear factor of activated T-cells, [7] [8] [9] interlacing Ca 2þ signalling with the induction of specific gene activation. 10, 11 STIM1 downregulation in cultured VSMC is associated with cell growth retardation, decreased cell proliferation and migration. 9, 12, 13 STIM1 is also responsible for mediating focal adhesion (FA) assembly and disassembly and cytoskeleton dynamics. 14, 15 In vivo, STIM1 and Orai downregulation prevent injury-induced neointima formation in carotid arteries of rodents. [7] [8] [9] SOCE is not an exclusive prerogative of proliferative VSMC. Recent studies have provided evidence for the presence of STIM1 and Orai in native VSMC isolated from the aorta and mesenteric arteries of rodents. [7] [8] [9] 16, 17 STIM1 and Orai1 are both upregulated in the tunica media of the aorta in spontaneously hypertensive rats. 17 Interestingly, treatment with STIM1 or Orai1 neutralizing antibodies abolished basal tone differences between normotensive and hypertensive rats, 17 suggesting STIM1-dependent SOCE as a potential target for the treatment of spontaneous hypertension. 17 Collectively, these observations provide clear evidence in support of a role of STIM1 and ORAI1 during cytoskeletal processes that occur during contractile activation of SMCs and those that govern cell motility and migration. 18, 19 However, the exact mechanisms of action of STIM1 and SOCE in VSMC still remains elusive.
In humans, loss-of-function mutations in STIM1 and ORAI1 genes cause severe combined immunodeficiency (SCID) associated with iris hypoplasia, mydriasis and primary enuresis with underlying smooth muscle hypoplasia. 20 Unfortunately, given the severity of SCID and its complexity, no data is available regarding the functions of other smooth muscles such as those within the walls of blood vessel and those in the digestive tract. Moreover, persistent and severe infection secondary to SCID may influence smooth muscle phenotype. Since global STIM1 gene deletion has a lethal phenotype in the mouse, smooth muscle-specific STIM1-deficient mice (sm-STIM1 KO) represents a powerful tool for elucidating STIM1 function in smooth muscle tissue, circumventing other confounding variables. Indeed, we have reported that sm-STIM1 KO mice exhibited profound morphological alterations of both vascular mural and visceral smooth muscle. 9 Despite this remarkable vascular phenotype, no difference in arterial pressure and cardiac function were reported in sm-STIM1 KO mice. 21 However, impaired smooth muscle structure/function can trigger complex compensatory mechanisms that normalize blood pressure (BP) and obscure the impact of STIM1 deletion in VSMC. This hypothesis remains untested.
Our primary goal for this study was to evaluate the impact of STIM1 loss in the smooth muscle on baseline cardiovascular functions including BP, and during Angiotensin II (Ang II)-induced hypertension. Our working hypothesis was that STIM1 deletion perturbs vascular integrity in adult mice, which in turn triggers compensatory changes that maintain BP within a normal physiological range. To test this, we used implantable telemetry probes that measure BP and heart rate (HR) in unrestrained mice. Determination of circulating plasma catecholamines was undertaken to investigate potential compensatory mechanisms that preserve BP in sm-STIM1 KO mice; immunolabeling techniques were used to examine the architecture of smooth muscle in tissue and subcellular cytoskeletal organization.
Our data show that smooth muscle-targeted STIM1 deletion causes decreased vascular tone with severe alterations of arterial morphology and function. Profound changes in smooth muscle containing organs other than arteries were also observed. No changes in basal BP were noted; in-depth analysis revealed high levels of circulating plasma catecholamines in sm-STIM1 KO mice. Cytoskeletal actin and vinculin distribution was profoundly altered in STIM1 KO VSMC. Although hypertrophic responses to Ang II infusion were blunted in sm-STIM1 KO mice, cardiac function declined rapidly in these mice. Our findings provide new evidence that STIM1 is essential for maintaining smooth muscle integrity at tissue and cellular levels.
Methods

Animal experiments
All experiments using mice were conducted under protocols approved by the Institutional Animal Care and Use Committee of the University of Tennessee Health Science Center. Unless specified, adult 8-to 15-week old mice (of either sex) were used in this study. The sm-STIM1 KO and control (ctrl) mice were generated previously in. 9 Briefly, STIM1 floxed mice were crossed with transgenic sm22-alpha cre-recombinase knockin mice (Jackson Laboratories, Cat. 4746) to make sm-STIM1 KO creþ/-mice. Transgenic STIM1 WT-creþ/-mice were used as controls. Mice were housed in a facility maintained at 22 C with an alternating 12-h light/dark cycle and were provided with ad libitum access to water and standard rodent chow.
Echocardiography
Age-and sex-matched mice were anaesthetized with isoflurane and placed on the warm pad of a recording stage of a Vevo 2100 ultrasound machine. The anterior chest was shaved, and ultrasound coupling gel applied, electrodes were connected to each limb and electrocardiogram was simultaneously recorded. Two-dimensional (short axis-guided) M-mode measurements (at the level of the papillary muscles) were taken using an 18-32 MHz MS400 transducer as previously described. 15, 22 Images were also recorded in the parasternal long-axis. For analysis purposes, three or more beats were averaged; measurements within the same HR interval (450 ± 50 bpm) were used for analysis.
Telemetric BP and HR measurements
BP was assessed by implantable radio transmitters as previously described in. 23 Briefly, mice (weight > 20 g) were implanted with transmitters (model HD-X11, Data Sciences International), while under isoflurane anaesthesia. The catheter tip was placed near the ascending aorta via the right carotid artery and the emitter inserted subcutaneously in the dorsal right flank. Animals were allowed to recover for 5-7 days before baseline recording started. HR, systolic blood pressure (SBP), diastolic blood pressure (DBP), and mean arterial pressure (MAP) were collected using Dataquest ART data acquisition system (Data Sciences International). Data were sampled continuously and stored on a hard disc for offline analysis with LabChart Pro8 (ADInstruments). In some experiments, recordings were paused to allow one injection of a freshly prepared solution containing prazosin (4 mg/kg, i.p.; Sigma), or hexamethonium (HEX) (5 mg/kg, i.p.; Sigma); drugs were dissolved in saline solution (0.9% NaCl) and were given intraperitoneally. Recordings were paused during the injection and started again 5 min after the animal was placed in its original cage, beat-by-beat values of BP and HR were recorded for one additional hour. Drugs were delivered by a single 
Blood sampling and determination of plasma components
Blood was collected from anaesthetized mice by a quick puncture of the submandibular vein. After clotting, the blood was centrifuged at 4 C (10 min, 400 g), serum was collected and stored at -80 C. For catecholamine and adrenocorticotropic hormone (ACTH) determination, glutathione was added at the time of collection; samples were then shipped on dry ice to the Assay and Analytical Services Core (Vanderbilt University Medical Center; Nashville, TN, USA). For determination of plasma levels of angiotensin II (Ang II), Renin 1 and angiotensin converting enzyme (ACE), ethylene diamine triacetic acid (EDTA), and protease inhibitors were added to the collecting tubes to prevent protein degradation. Enzymatic activity was measured using commercially available ELISA kits following the manufacturers' instructions (Sigma-Aldrich and BD Biosciences; San Jose, CA).
Pressurized artery diameter measurements
Experiments were performed using mesenteric arteries isolated from control and sm-STIM1 KO mice. Intact artery segments (1-2 mm in length) were cannulated at each end of the micropipette in a perfusion chamber (Living Systems Instrumentation, St Albans, VT, USA) that was maintained at 37 C and continuously perfused with physiological saline solution (PSS, containing 112 mM NaCl, 4.8 mM KCl, 24 mM NaHCO3, 1.2 mM KH2PO4, 1.8 mM CaCl2, 1.2 mM MgSO4, and 10 mM glucose), gassed with 21% O 2 , 5% CO 2 , 74% N 2, (pH =7.4). The intravascular pressure was monitored using a pressure transducer and altered using an attached reservoir. Arterial diameter was measured at 1 Hz using a CCD camera attached to a Nikon TS100-F microscope and the automatic edge-detection IonWizard software (Ionoptix, Milton, MA, USA 
Mesenteric artery contraction myography
Mesenteric artery contractility was measured with a multi-channel wire myograph (model 610 M, Danish Myo Technology; Aarhus, Denmark) and LabChart software (ADInstruments). Mesenteric artery segments (first and second order) were mounted on tungsten wires and allowed to equilibrate for $30 min at 37 C in PSS buffer (bubbled 21% O 2 , 5% CO 2 , 74% N 2, (pH =7.4). Vessel tension was normalized to 0.9 times the internal circumference at 100 mmHg transmural pressure. Arterial contractility was optimized with KCl (60 mM) before performing a phenylephrine (PE) concentration-response curve.
Tissue collection and processing
Mice were euthanized with an excess of isoflurane followed by cervical dislocation. Each mouse was perfused with isotonic saline delivered by a 22 G needle catheter placed in the left ventricular chamber via a cardiac puncture. Organs were collected and stored at -80 C for protein extraction. In some animals, once the perfusate cleared, saline was switched to 4% formaldehyde fixative; tissues were collected and kept in formaldehyde for an additional 48 h and then transferred to 70% alcohol until ready for tissue processing. Paraffin-embedded tissue was sectioned at 5 mm, deparaffinized with serial passages in xylene substitute and alcohols, and treated for trichrome or hematoxylin-and-eosin (H&E) staining following standard protocols. Immunohistochemistry was performed after tissue was properly deparaffinized and permeabilized. Tissue was then incubated with blocking solution for 20 min followed by overnight incubation with primary antibodies. The next day, the excess primary antibody was washed and secondary antibody applied. Finally, the specimens were mounted with medium containing 4',6-diamidino-2-phenylindole (DAPI) (Thermo Fisher Scientific). Images were taken using a Zeiss LSM 710 confocal microscope and were later analysed using ImageJ.
Smooth muscle isolation and culture
Primary SMCs were isolated from sm-STIM1 KO or ctrl mice as described previously in. 9 Briefly, aortic SMCs were isolated using collagenase digestion (Worthington Type 2, 1 mg/ml; Worthington Biochemical Corp., Lakewood, NJ, USA) and elastase (Worthington, 0.2 mg/ml). Dispersed SMC were grown in Dulbecco's modified Eagle's medium containing 20% foetal bovine serum and penicillin/streptomycin, passaged by trypsinization, and used for experiments until Passage 1. Cells were then fixed in 4% formaldehyde and stored for immunocytochemistry. For total cell area measurements cells were formalin-fixed after 2 h (at Passage 1) cell perimeter was visualized (20Â magnification) and measured by drawing a line around the cell body and measurement of total cell area was automatically calculated (ImageJ software). Only individual cells were used for quantification. Pictures were obtained from 3 different cultures. Quantification of phalloidin (F-actin) and vinculin staining was performed from images of cells acquired using a Zeiss 710 confocal microscope with 63Â objective. Confocal images of the basal plane of phalloidin-and vinculin-labelled VSMC were taken using the same gain and offset settings. Phalloidin and vinculin positive fibres were quantified, and the background pixel intensity was subtracted. Mean fluorescence intensity was calculated using ImageJ.
Western blot
Total proteins were isolated from mouse tissue homogenates in the presence of lysis buffer (RIPA buffer, Sigma-Aldrich) enriched with protease inhibitors (Pierce; Waltham, MA, USA) and PMSF (0.2 mM).
Proteins were quantified using a BCA colorimetric assay (Pierce; Waltham, MA, USA), separated by SDS-PAGE, and transferred to a PVDF low-fluorescence membrane. Membranes were blocked with 5% non-fat milk dissolved in TBST for 1 h at room temperature, followed by incubation with primary antibodies (O/N at 4 C). The excess primary antibody was then washed out, and secondary antibody was added and incubated at RT for 1 h, followed by four washes with TBST (5 min each). Images were collected using the LI-COR Odyssey infra-red imaging system (LI-COR Biotechnology; Lincoln, NE, USA 
Data analysis
All results are expressed as mean ± S.E.M., and n = sample size (n represents the number of cells, animals, or independent experiments). Concentration-response curves were fitted with sigmoidal doseresponse equations with variable slope, which revealed maximum contraction and (the logarithm of) the concentration for each vessel segment. The influence of genotype, drug treatments were assessed by a one-or two-way analysis variance (ANOVA), with Bonferroni's posttest, or Student's t-test where appropriate, calculated with GraphPad Prism7 (GraphPad Software; San Diego, CA, USA). Data from in vitro experiments were analysed with nested ANOVA that considers both the number of wells and the number of experiments. For all statistical comparisons, statistical significance was set at P < 0.05.
Results
STIM1 deletion in smooth muscle causes reduced pressure-induced myogenic tone in mesenteric arteries
High Cre-recombinase expression under the endogenous sm22-alpha actin promoter induced an efficient recombination of the STIM1-floxed gene. STIM1 protein expression ($80 kDa) was visible in all control arteries and myocardium, but it was significantly reduced in smooth muscle and myocardium isolated from adult sm-STIM1 KO mice ( Figure 1A and B). Data variation was probably due to contamination from cells other that smooth muscle still expressing STIM1 protein. In contrast to global STIM1 knockout, which is lethal in mice, 24 targeted sm-STIM1 KO mice survived to adulthood, 9 allowing a full assessment of the compensatory and structural changes caused by deletion of STIM1. Figure 1C illustrates the rate-dependent contractile response of isolated mesenteric arteries to stepwise increases in intraluminal pressure (myogenic tone). At intravascular pressures between 40 and 100 mmHg, arteries from sm-STIM1 KO mice developed less myogenic tone than arteries from control mice ( Figure 1C and D) . For example, at 60 mmHg control arteries developed $24.5% mean tone, whereas sm-STIM1 KO mouse arteries developed $14.0% tone, or 57.1% of controls ( Figure 1C  and D) . At maximal internal pressure (100 mmHg) a bolus of PE was applied to induce vasoconstriction, PE-induced vasoconstriction was smaller in sm-STIM1 KO arteries when compared with control arteries ( Figure 1C and E) . In contrast, high K þ (60 mM), which depolarizes arteries, thereby activating voltage-dependent Ca 2þ channels, similarly constricted control and sm-STIM1 KO arteries ( Figure 1E) . The passive pressure-diameter in control and sm-STIM1 KO arteries was similar 3.2 sm-STIM1 KO mice exhibit tachycardia but near normal arterial BP Attenuated myogenic tone and reduced PE-induced vasoconstriction may result in changes in BP in sm-STIM1 KO mice. Radio-telemetry in conscious, free moving mice, was used to measure the effects of sm-STIM1 deletion on resting BP. Continuous BP and HR measurements were taken each 24 h period over five consecutive days. There was no significant difference in MAP between sm-STIM1 KO mice and the control group, 107 ± 15 vs. 103 ± 22 mmHg, respectively ( Figure 2A ; P > _ 0.05). Similar trends were observed in SBP and DBP during both dark and light cycle intervals ( Figure 2B and C) . Surprisingly, sm-STIM1 KO mice exhibited a significantly higher HR than their control counterpart: (669 ± 22 vs. 575 ± 10 bpm during the dark interval, and 649 ± 18 vs. 520 ± 9 bpm during the light interval, Figure 2D ; P < 0.05). Although it was possible to appreciate circadian fluctuations in the systemic haemodynamics from control mice, the circadian rhythm was less pronounced in sm-STIM1 KO mice.
Plasma catecholamine levels are upregulated in sm-STIM1 KO mice
A complex interplay of several mechanisms maintain BP within a narrow physiological range. Disruption or alteration of one of those mechanisms activates complicated compensatory responses to preserve circulatory homeostasis and maintain BP. We focused our attention on the strong relationship between sympathetic neural activity and BP regulation. Indeed, increased sympathetic nerve activity has been found in many hypertensive animals, 25 and in human patients with hypertension. 26 Therefore, we investigated whether sympathetic activation was a compensatory response to the loss of myogenic tone. Plasma concentrations of epinephrine were threefold higher in sm-STIM1 KO mice when compared with control mice ( Figure 3A) . Consistently, plasma norepinephrine was higher by $50% compared with plasma obtained from control mice ( Figure 3B ). Albeit plasma renin concentration in sm-STIM1 KO mice was high as compared with controls, there was no difference between the two groups. Circulating Ang II and ACTH concentrations showed no differences ( Figure 3C -E).
Sympathetic inhibition markedly decreases BP in sm-STIM1 KO mice
We tested the hypothesis that increased levels of circulating plasma catecholamines mask the effects of STIM1 removal, maintaining MAP near physiological levels in sm-STIM1 KO mice. MAP and HR were measured simultaneously before and after treatment with prazosin, a a1-adrenergic receptor inhibitor. After a single prazosin injection, in control mice MAP dropped from 111 ± 3 to 96 ± 5 mmHg. However, sm-STIM1 KO mice exhibit a greater reduction in MAP, dropping from 116 ± 6 to 77 ± 7 mmHg, ( Figure 4A and B) . In control mice administration of prazosin induced an increase in HR, as a result of stimulation of the b-adrenergic adrenoceptor. 27 Conversely, HR in sm-STIM1 KO mice did not increase after prazosin treatment ( Figure 4C and D) . To further examine the sympathetic influence on the peripheral vascular resistance in sm-STIM1 KO mice, MAP was measured before and after ganglionic blockade with HEX (5 mg/kg, i.p.), a well-known nicotinic acetylcholine receptor blocker. 28 When sympathetic activity was blocked, sm-STIM1 KO mice showed a larger reduction in BP than the control counterpart, (Figure 4E and F) . Overall, these results suggest that the sympathetic system activation supports hemodynamic homeostasis by balancing the impaired myogenic tone observed in sm-STIM1 KO mice.
Cytoskeletal alteration in SMC from sm-STIM1 KO mice
Structural components of the cytoskeleton are fundamentally important for maintaining cell shape and integrity. We have recently reported that STIM1 contributes significantly to the arrangement of cytoskeletal architecture during cardiac remodelling. 15 Furthermore, smooth muscle contraction is regulated by the cytoskeletal proteome network. Given the lack of myogenic tone in sm-STIM1 KO mice, we sought to determine whether STIM1 is involved in the cytoskeletal organization in these cells. Cultured VSMC isolated from control arteries were very rich in actin fibres oriented along the longest axis of the cell. Large, well-organized clusters of vinculin, representing the formation of FA contacts, were visible and uniformly distributed over the entire cell area particularly at the end of actin-filaments bundles and around the edge of the cell membrane ( Figure 5A, a-c) .
In contrast, STIM1 KO cells showed profound cytoskeletal alterations revealed by decreased actin-rhodopsin fluorescence intensity, indicating reduced presence of polymerized actin ( Figure 5A and B) . Furthermore, the number of FAs, corresponding to vinculin staining, was also significantly reduced ( Figure 5A and C) . On average cultured STIM1 KO cells consistently display reduced cell total area ( Figure 5D ). Reduction of actin staining intensity was found also at tissue level in aortas isoalted from sm-STIM1 KO mice (see Supplementary material online, Figure S1A ). Several smooth muscle containing organs were affected by STIM1 loss at multiple levels by showing structural abnormalities and altered vascularization (see Supplementary material online, Figure S1A-C) . This series of experiments document that STIM1 has profound effects on FA formation and cytoskeletal organization in SMCs.
3.6 Angiotensin II infusion does not induce hypertension in sm-STIM1 KO but exacerbates cardiac fibrosis, leading to the rapid decline of heart function Recently, it has been reported that STIM1 contributes significantly to the abnormal vascular function in hypertension. 17 Furthermore, both smooth muscle or cardiac-restricted STIM1 downregulation is protective against cardiac hypertrophy. 15,29 Given the pathophysiological relevance of these observations, we further tested the effect of Ang II-induced hypertension on the vascular system and the cardiac function of sm-STIM1 KO mice. Chronic subcutaneous administration of Ang II for two weeks significantly increased BP in control mice to the degree comparable to previous studies. 30 In contrast, sm-STIM1 KO animals showed only a modest increase in BP ( Figure 6A and B) . In line with these findings, four weeks of Ang II infusion in control mice resulted in cardiac hypertrophy as revealed by a significant increase in heart weight/body weight ratio. Conversely, sm-STIM1 KO mice reported less hypertrophy after continued Ang II infusion ( Table 1) . Histologic analysis of hearts from sm-STIM1 KO exhibited increase interstitial fibrosis with focal areas already at baseline (no Ang II infusion), which was absent in control hearts ( Figure 1C) . However, the echocardiographic analysis did not show significant changes in cardiac functions between the two groups ( Table 1) . Fibrosis was prominent after chronic Ang II infusion. Indeed, sm-STIM1 KO mice exhibited significantly larger fibrotic areas when compared with their control counterparts ( Figure 6C-E) . The presence of cardiac fibrosis was corroborated by increased expression levels of periostin, a cardiac fibrotic marker ( Figure 6D-F) . Cardiac function was compromised as showed by reduced fractional shortening and ejection fraction ( Table 1) . These results suggest that although the sm-STIM1 KO mice are protected from Ang II-induced hypertension, these mice cannot sustain the additional stress imposed by chronic Ang II infusion.
Discussion
In this study, we sought to determine the role of STIM1 in the cardiovascular system by characterizing phenotypic and functional changes that occur in sm-STIM1 KO mice. We have previously shown that these mice exhibit a vascular phenotype encompassing structural vascular defects and premature death. 9 At the cellular level, STIM1 downregulation in smooth muscle impairs intracellular signalling, decreases proliferation . Aortic VSMC were isolated from three independent isolations, for each isolation several aortas were pooled together to increase cell yield. Mean ± 95% CI. Each dot represents the average measurements from one field (n = number of fields). Nested ANOVA was applied for statistical analysis, *P < 0.05. Scale bar = 50 mm. and migration. 9, 12 In light of these earlier reports, it was important to investigate the consequences of STIM1 deletion on arterial function. We show that myogenic tone developing in response to pressure was dramatically decreased by STIM1 deletion. Structural damages are observed in several smooth muscle-containing organs. STIM1 KO VSMC displayed reduced total cell area and displayed compromised cytoskeleton as revealed by altered actin and vinculin distribution. Although these results may suggest an impaired hemodynamic activity, resting BP in sm-STIM1 KO mice was similar to their control counterpart, confirming previously published data using the same animal model. 21 However, our data suggest that elevated circulating plasma catecholamines mask the reduced myogenic tone of peripheral microvasculature observed in sm-STIM1 KO mice. This is supported by evidence showing that sympathetic activity is involved in the long-term BP regulation. 15, 31, 32 In keeping with our findings, elevated circulating catecholamine levels present in sm-STIM1 KO mice disrupt the BP circadian variation, which is controlled by sympatho-adrenergic activity. 33 A possible role of ACTH-induced glucocorticoids in the BP regulation of sm-STIM1 KO mice was ruled out by direct measurements of plasma ACTH. However, ACTH levels were highly variable in sm-STIM1 KO mice. Impaired vascularization and abnormal blood supply to the pituitary gland may be responsible for the ACTH variability. This will need further investigation.
The high susceptibility of sm-STIM1 KO mice to selective inhibition of a-adrenergic receptors and ganglion-blocking drugs indicate hyperactivity of the preganglionic sympathetic nerves, which leads to the release of high levels of epinephrine from the adrenal medulla. An additional primary source of circulating norepinephrine is spill-over from sympathetic nerves innervating blood vessels. Normally, most norepinephrine released by sympathetic nerves is taken back up and metabolized. Our data suggest that high sympathetic nerve activation and structural arterial damage in sm-STIM1 KO mice increase norepinephrine spillover from sympathetic nerves resulting in high circulating plasma catecholamines.
We and others have reported that sm-STIM1 KO significantly reduces agonist-induced vasoconstriction. In contrast, high K þ -induced depolari- arterial structural damages observed in sm-STIM1 KO vessels. In contrast, PE-induced contraction and myogenic tone rely in great part on the structure of the cytoskeleton and tissue integrity. However, the two pathways are not mutually exclusive, and the mediators of these interactions are not completely understood. 37 The observation that STIM1 removal alters VSMC cytoskeletal integrity explains the compromised structure of smooth muscle containing organs, highlighting the complex relationships between cytoskeletal integrity and vascular reactivity. These findings support the view of a new STIM1 function in mediating cytoskeletal rearrangement by altering FA turnover. Other studies have implicated STIM1 in FA turnover in several cell types. 14, 15, 38, 39 Accordingly, our results suggest a central role of STIM1 in maintaining cytoskeleton integrity in SMCs. At baseline, sm-STIM1 KO hearts revealed the presence of myocardial fibrosis. This is probably associated with cell damage induced by high circulating catecholamines through mechanisms involving a reduction in intracellular glutathione and accumulation of reactive oxygen radicals. 40 Echocardiographic analysis of sm-STIM1 KO mice and control mice did not show significant cardiac dysfunction. This could be attributable to the fact that echocardiographic measurements are dependent on loading conditions and often not reliable in diseases with significant vascular alteration. The role of sympathetic activity in the pathogenesis of cardiac fibrosis has been demonstrated before, 41 and it is supported by the data showing that sympathectomy significantly attenuate left ventricular fibrosis independently of BP. 42 This further demonstrates the role of sympathetic activity in the pathogenesis of cardiac fibrosis independent of BP.
Recently published data have shown that sm-STIM1 KO mice are protected against Ang II-induced hypertension and cardiac hypertrophy. In the same study, the authors found that Ang II infusion did not induce cardiac fibrosis in sm-STIM1 KO hearts. 15, 29 Our data confirm sm-STIM1 KO mice blunted hypertensive response to chronic Ang II infusion. However, we found increased cardiac fibrosis in sm-STIM1 KO hearts associated with impaired cardiac function after 4 weeks of Ang II treatment. The cardiac fibrosis observed at baseline can be attributed to high circulating catecholamine. Hence, exacerbation associated with impaired cardiac function during chronic Ang II infusion is to be expected. Another possible explanation for increased fibrosis in STIM1 KO hearts may come from altered coronary artery structure that likewise the blood vessels in the villi may be impaired; this could lead to inadequate coronary perfusion, contributing to cardiac damage and declined of cardiac function. STIM1 KO hearts did not develop significant cardiac hypertrophy after Ang II infusion, but in this regard, it is worth mentioning that STIM1 deletion from the myocardium has been reported to prevent pressure-induced cardiac hypertrophy. 15, 42 Further research is needed to determine how sm-STIM1 KO affects organ vascularization and the molecular mechanisms of fibrotic response in these mice. In addition to increased susceptibility to infection, a subpopulation of SCID patients also exhibit gastrointestinal disorders. 20, 43 Interestingly, targeted sm-STIM1 loss in mice causes adverse effects such as enlargement of the oesophagus and intestine associated with loss of vasculature that contribute to premature death. The impaired vascular tone suggests that intestinal muscular tone is likely to be also negatively affected in sm-STIM1 KO mice. Hence, our mouse model could be suitable for addressing pathophysiological roles of STIM1 in gastrointestinal disorders associated with SCID. Taken together, our data provide a comprehensive picture of the role of STIM1 in smooth muscle and the cyrculatory ststem. However, as we gain new insights on STIM1 function in smooth muscle, new questions arise. Further investigations are waranted to unveil downstream biological effectors that mediate cytoskeletal remodelling associated with STIM1. It will be important to identify which is the predominant Orai isoform that mediates Ca 2þ entry in smooth muscle and if their expression and function differ in smooth muscle from different tissues and between contractile/proliferative phenotypes. Moreover, our data caution against previous reports describing a protective role of STIM1 deletion against hypertension and cardiac fibrosis. As new drugs are developed to inhibit SOCE as treatment of certain inflammatory conditions, particular attention should be paid to possible side effects on the cardiovascular system, expecially when prexisting conditions such as hypertension or impaired cardiac function are present. Heart-weight/body-weight (mg/g) 5.5 ± 0. 
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